Citations 91

A population-based approach to chemotherapy-induced peripheral neuropathy reveals the disease burden of early and late effects (P5.117)

Neurology | December 7, 2023 | Volume: 88 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.88.16_supplement.p5.117

Analysis of mesenchymal stromal cell phenotype in the cerebrospinal fluid environment via in vitro transcriptomics and in vivo data from an ALS clinical trial (1336)

Neurology | December 7, 2023 | Volume: 96 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.96.15_supplement.1336

Population Characteristics and Progression to Disability Among Patients with Small Fiber Neuropathy (2538)

Neurology | December 7, 2023 | Volume: 94 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.94.15_supplement.2538

A Population Based Assessment of Polyneuropathy and Associated Disability (S58.003)

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.s58.003

MRI and PET Imaging Discordance in Neurosarcoidosis (P06.205)

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.p06.205

Nerve Biopsy Supports Ischemic Axonal Neuropathy in Meralgia Paresthetica (P02.178)

Neurology | December 7, 2023 | Volume: 80 | Issue: 7_supplement | Pages: No page available

10.1212/wnl.80.7_supplement.p02.178

Progressive Autoimmune Neuromyotonia with Low Voltage-Gated Potassium Channel-Complex IgG and CASPR2-IgG Following Remote Inflammatory Polyradiculoneuropathy (P4.019)

Neurology | December 6, 2023 | Volume: 84 | Issue: 14_supplement | Pages: No page available

10.1212/wnl.84.14_supplement.p4.019

Cranial EMG helps differentiate SBMA from ALS regardless of bulbar symptoms (P3.172)

Neurology | December 6, 2023 | Volume: 84 | Issue: 14_supplement | Pages: No page available

10.1212/wnl.84.14_supplement.p3.172

Clinical and Electrophysiological Findings in C9orf72 ALS (P2-13.006)

Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available

10.1212/wnl.98.18_supplement.3374

CSF biomarkers evaluated by principal component analysis in a NurOwn Phase 3 clinical trial (P1-1.Virtual)

Neurology | December 6, 2023 | Volume: 98 | Issue: 18_supplement | Pages: No page available

10.1212/wnl.98.18_supplement.2796